OmniLife’s story began in 2016 when our co-founders, Dalton Shaull and Eric Pahl - both students at the University of Iowa – first connected through their common interest in medical technology and their shared connected purpose to organ and tissue transplant.
Dalton, a former division one athlete at the University of Iowa, suffered career ending injuries from a near-fatal motorcycle accident during his sophomore year. One of the injuries (to his brachial plexus) left him with a paralyzed right arm. After about a year, during which his arm was paralyzed, Dalton underwent an experimental nerve transplant operation and eventually was able to regain full movement of his arm.
Eric, pursuing his Ph.D. in Health Informatics at the University of Iowa, became interested in transplant when his aunt passed away while waiting for a life-saving liver transplant. Determined to better understand the organ allocation system, Eric started to study the UNOS/SRTR Star file data. In his research, Eric uncovered discrepancies that lead to numerous questions and sparked his interest to further understand clinical workflows and systems.
Dalton and Eric’s connected purpose and passion for the organ and tissue transplant industry led them to establish OmniLife, originally named HealthTech Solutions, in 2016.
The main challenge
There are 120,000+ patients waiting for organs with 22 patients dying every day with limited accessibility to life-saving organ transplants.
This statistic drove Dalton and Eric to better understand the ins and outs of the organ transplant process and industry. They wanted to experience the challenges that Transplant Centers and OPOs face every day in their daily communication and decision-making. To do this, Dalton and Eric shadowed transplant coordinators, transplant surgeons, transplant physicians etc. By standing in the shoes of every key stakeholder in the transplant process they were able to understand the areas where they could improve the communication between an OPO and Transplant Center during an organ offer and evaluation, procurement and recovery, and transplant.
This led them to the realization that communication was one of the biggest challenges in the transplant process. With so many individuals involved in the process, it can be extremely challenging to keep the entire team on the same page with each transplant. To help improve communication, Dalton and Eric set out to develop a phone and desktop application that adds efficiency, ease, and security to the communication between all of the professionals involved in the organ transplant process.
They were awarded an NIH SBIR Phase 1 research grant, received additional donations from state-based grants, as well as investments from individuals passionate about improving donation and transplantation. Thanks to this support, they were able to develop OmniLife’s first product, TXP Chat™, which launched in 2017.
The trial run
In 2017, OmniLife ran a research trial with Iowa Donor Network and the Iowa Transplant Centers. The outcomes of the study were positive and showed that TXP Chat™ reduced phone calls for clinical staff by over 50%, significantly reduced the amount of time between initial offer and final decision, all while improving team collaboration, coordination, and case awareness as measured by an improved Relational Coordination Score (RCA survey). The net result of reducing organ evaluation time, which increased offer throughput, enabling 22 additional organ transplants that wouldn’t have happened otherwise (a 35% increase).
In 2018, OmniLife continued to gain support from generous investors, medical professionals and organizations. TXP Chat™ has continued to evolve and adapt to meet the communication and data needs of all the medical professionals involved in the transplant process. This application now has additional features which include clinical support that helps with logistics and predicts whether an organ transplant is likely to be successful before the transplant occurs.
With this growth also brought the change from our original name, HealthTech Solutions, to OmniLife. This name change allows us to better express our company mission: to be a patient-focused platform that connects the entire transplant care continuum. The OmniLife team also started to grow, welcoming new members to our staff, including an engineering team, marketing experts, and sales professionals.
The Care Continuum
At OmniLife, we are passionate about assisting everyone who is a part of the transplant care continuum. We are driven to provide efficiency to their jobs and help them focus on improving access and quality of care for their patients. Our communication-centric products remove barriers and streamline workflows to enhance care coordination between providers and patients. It is our goal to be a cost-effective platform that allows organ transplant to be a viable treatment option for both the provider and the patient which will ultimately lead to more lives being saved.
Join us as we build connections in an effort to ensure that patients receive the full benefit from each gift of life.